{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:40:47Z","timestamp":1789782047623,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1007\/bf03032573","type":"journal-article","created":{"date-parts":[[2009,9,27]],"date-time":"2009-09-27T19:36:43Z","timestamp":1254080203000},"page":"85-94","source":"Crossref","is-referenced-by-count":64,"title":["Angiogenesis-dependent diseases and angiogenesis therapy"],"prefix":"10.1007","volume":"7","author":[{"given":"J\u00f3zsef","family":"T\u00edm\u00e1r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"D\u00f6me","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e1roly","family":"Fazekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Janovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"Paku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03032573_CR1","first-page":"289","volume":"12","author":"A Albini","year":"1996","unstructured":"Albini A, Benelli R, Presta M, et al: HIV-tat protein is a heparin binding angiogenic growth factor. Oncogene 12:289\u2013297, 1996.","journal-title":"Oncogene"},{"key":"BF03032573_CR2","doi-asserted-by":"crossref","first-page":"13588","DOI":"10.1074\/jbc.275.18.13588","volume":"275","author":"DG Bae","year":"2000","unstructured":"Bae DG, Gho YS, Yoon WH, et al: Arginic-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis. J Biol Chem 275:13588\u201313596, 2000.","journal-title":"J Biol Chem"},{"key":"BF03032573_CR3","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1074\/jbc.275.3.1521","volume":"275","author":"T Bowder","year":"2000","unstructured":"Bowder T, Folkman J, Pine-Shepherd S: The hemostatic system as a regulator of angiogenesis. J Biol Chem 275:1521\u20131524, 2000.","journal-title":"J Biol Chem"},{"key":"BF03032573_CR4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1357-4310(00)01677-4","volume":"6","author":"JM Brown","year":"2000","unstructured":"Brown JM: Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Molecular Medicine Today 6:157\u2013162, 2000.","journal-title":"Molecular Medicine Today"},{"key":"BF03032573_CR5","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/S0959-8049(96)00390-5","volume":"32A","author":"F Bussolino","year":"1996","unstructured":"Bussolino F, Albini A, Camussi G, et al: Role of soluble mediators in angiogenesis. Eur J Cancer 32A:2401\u20132412, 1996.","journal-title":"Eur J Cancer"},{"key":"BF03032573_CR6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","volume":"6","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nature Medicine 6:389\u2013395, 2000.","journal-title":"Nature Medicine"},{"key":"BF03032573_CR7","doi-asserted-by":"crossref","first-page":"14608","DOI":"10.1073\/pnas.97.26.14608","volume":"97","author":"YS Chang","year":"2000","unstructured":"Chang YS, di Tomaso E, McDonald DM, et al: Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA 97:14608\u201314613, 2000.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03032573_CR8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/cbr.2000.15.71","volume":"15","author":"SJ DeNardo","year":"2000","unstructured":"DeNardo SJ, Burke PA, Leigh BR, et al: Neovascular targeting with cycle RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy. Cancer Biotherapy Radiopharmaceuticals 15:71\u201379, 2000.","journal-title":"Cancer Biotherapy Radiopharmaceuticals"},{"key":"BF03032573_CR9","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1172\/JCI6869","volume":"103","author":"BP Elicieri","year":"1999","unstructured":"Elicieri BP, Cheresh DA:The role of \u03b1v integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 103:1227\u20131230, 1999.","journal-title":"J Clin Invest"},{"key":"BF03032573_CR10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(94)90187-2","volume":"79","author":"IJ Fidler","year":"1994","unstructured":"Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185\u2013188, 1994.","journal-title":"Cell"},{"key":"BF03032573_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27\u201331, 1995.","journal-title":"Nat Med"},{"key":"BF03032573_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1026575610124","volume":"19","author":"S Gately","year":"2000","unstructured":"Gately S: The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metast Reviews 19:19\u201327, 2000.","journal-title":"Cancer Metast Reviews"},{"key":"BF03032573_CR13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353\u2013364, 1996.","journal-title":"Cell"},{"key":"BF03032573_CR14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1358836X0000500107","volume":"5","author":"MO Hiltunen","year":"2000","unstructured":"Hiltunen MO, Turunen MP, Laitinen M, et al: Insights into the molecular pathogenesis of atherosclerosis and therapeutic strategies using gene transfer. Vasc Med 5:41\u201348, 2000.","journal-title":"Vasc Med"},{"key":"BF03032573_CR15","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","volume":"284","author":"J Holash","year":"1999","unstructured":"Holash J, Maisonpierre PC, Compton D, et al: Vessel cooption, regression and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994\u20131998, 1999.","journal-title":"Science"},{"key":"BF03032573_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nm0295-149","volume":"1","author":"L Holmgren","year":"1995","unstructured":"Holmgren L, O\u2019Reilly MS, Folktnan J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149\u2013153, 1995.","journal-title":"Nat Med"},{"key":"BF03032573_CR17","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI6889","volume":"103","author":"JM Isner","year":"1999","unstructured":"Isner JM, Asahara T: Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103:1231\u20131235, 1999.","journal-title":"J Clin Invest"},{"key":"BF03032573_CR18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)64939-5","volume":"156","author":"BS Jacobson","year":"2000","unstructured":"Jacobson BS: Hereditary hemorrhagic telangiectasia a model for blood vessel growth and enlargement. Am J Path 156:737\u2013742, 2000.","journal-title":"Am J Path"},{"key":"BF03032573_CR19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/71517","volume":"6","author":"B Jim\u00e9nez","year":"2000","unstructured":"Jim\u00e9nez B, Volpert OV, Crawford SE et al Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nature Medicine 6:41\u201348, 2000.","journal-title":"Nature Medicine"},{"key":"BF03032573_CR20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/carcin\/21.3.505","volume":"21","author":"RS Kerbel","year":"2000","unstructured":"Kerbel RS: Tumor angiogenesis: past, present and the near future. Carcinogenesis 21:505\u2013515, 2000.","journal-title":"Carcinogenesis"},{"key":"BF03032573_CR21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee P, Wang CC, Adamis AP: Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 43:245\u2013269, 1998.","journal-title":"Surv Ophthalmol"},{"key":"BF03032573_CR22","first-page":"519","volume-title":"Lessons to be learned from clinical trials of angiogenesis modulators in ischemic diseases","author":"WW Li","year":"2000","unstructured":"Li WW Jaffe M, Li VW, et al: Lessons to be learned from clinical trials of angiogenesis modulators in ischemic diseases. In G.M. Rubanyi, (eds.), Marcel Dekker, Inc. New York, Basel, 2000, pp. 519\u2013536."},{"key":"BF03032573_CR23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S1076-6332(00)80629-7","volume":"7","author":"WW. Li","year":"2000","unstructured":"Li WW. Tumor angiogenesis: molecular pathology, therapeutic targeting and imaging. Acad Radiol 7:800\u2013811, 2000.","journal-title":"Acad Radiol"},{"key":"BF03032573_CR24","first-page":"373","volume":"4","author":"KJ Luzzi","year":"1998","unstructured":"Luzzi KJ, Varghese HJ, MacDonald IC, et al: Arginie-rich antivascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis. J Biol Chem 4:373\u2013379, 1998\/1999.","journal-title":"J Biol Chem"},{"key":"BF03032573_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1026443925807","volume":"17","author":"H Malonne","year":"1999","unstructured":"Malonne H, Langer I, Kiss R, et al: Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors. Clin exper Metastasis 17:1\u201314, 1999.","journal-title":"Clin exper Metastasis"},{"key":"BF03032573_CR26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","volume":"155","author":"AJ Maniotis","year":"1999","unstructured":"Maniotis AJ, Folberg R, Hess A, et al: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739\u2013752, 1999.","journal-title":"Am J Pathol"},{"key":"BF03032573_CR27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0968-0896(98)00090-X","volume":"6","author":"KC Nicolaou","year":"1998","unstructured":"Nicolaou KC, Trujilo JI, Jandeleit B, et al: Design, synthesis and biological evaluation of nonpeptide integrin antagonists. Bioorg Med Chem 6:1185\u20131208, 1998.","journal-title":"Bioorg Med Chem"},{"key":"BF03032573_CR28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/bbrc.1999.1840","volume":"267","author":"D Nie","year":"2000","unstructured":"Nie D, Lamberti M, Zacharek A, et al: Thromboxane A (2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochem Biophys Res Commun 267:245\u2013251, 2000a.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF03032573_CR29","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1182\/blood.V95.7.2304","volume":"95","author":"D Nie","year":"2000","unstructured":"Nie D, Tang K, Diglio C, et al: Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase. Blood 95:2304\u20132311, 2000b.","journal-title":"Blood"},{"key":"BF03032573_CR30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","volume":"79","author":"MS O\u2019Reilly","year":"1994","unstructured":"O\u2019Reilly MS, Holmgren L, Sning Y, et al: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315\u2013328, 1994.","journal-title":"Cell"},{"key":"BF03032573_CR31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","volume":"88","author":"MS O\u2019Reilly","year":"1997","unstructured":"O\u2019Reilly MS, Boehm T, Shing Y, et al: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277\u2013285, 1997.","journal-title":"Cell"},{"key":"BF03032573_CR32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF02904699","volume":"4","author":"S Paku","year":"1998","unstructured":"Paku S: Current concepts of tumor-induced angiogenesis. Pathol Oncol Res 4:62\u201375, 1998.","journal-title":"Pathol Oncol Res"},{"key":"BF03032573_CR33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1026543018478","volume":"19","author":"VS Pribluda","year":"2000","unstructured":"Pribluda VS, Gubish ER, La Vallee, TM, Jr, et al Methoxyestradiol: An endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metast Reviews 19:173\u2013179, 2000.","journal-title":"Cancer Metast Reviews"},{"key":"BF03032573_CR34","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1073\/pnas.91.4.1524","volume":"91","author":"R Sasisekharan","year":"1994","unstructured":"Sasisekharan R, Moses MA, Nugent MA, et al Heparinase inhibits neovascularization. Proc Nat Acad Sci USA 91:1524\u20131528, 1994.","journal-title":"Proc Nat Acad Sci USA"},{"key":"BF03032573_CR35","first-page":"3","volume":"15","author":"J Schiller","year":"1999","unstructured":"Schiller J: Early trials of antiangiogenic agents. Anticancer Agents in Oncology 15:3\u201310, 1999.","journal-title":"Anticancer Agents in Oncology"},{"key":"BF03032573_CR36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1023\/A:1006358220123","volume":"18","author":"J-M Schlaeppi","year":"1999","unstructured":"Schlaeppi J-M, Wood JM: Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors. Cancer Metastasis Rev 18:473\u2013381, 1999.","journal-title":"Cancer Metastasis Rev"},{"key":"BF03032573_CR37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1026544214667","volume":"19","author":"GL Semenza","year":"2000","unstructured":"Semenza GL: HIF-1: Using two hands to flip the angiogenic switch. Cancer Metast Reviews 19:59\u201365, 2000.","journal-title":"Cancer Metast Reviews"},{"key":"BF03032573_CR38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/(SICI)1096-9926(200003)61:3<189::AID-TERA6>3.0.CO;2-W","volume":"61","author":"TD Stephens","year":"2000","unstructured":"Stephens TD, Fillmore BJ: Hypothesis: Thalidomine embryopathy-proposed mechanism of action. Teratology 61:189\u2013195, 2000.","journal-title":"Teratology"},{"key":"BF03032573_CR39","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1172\/JCI6870","volume":"103","author":"WG Stetler-Stevenson","year":"1999","unstructured":"Stetler-Stevenson WG: Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 103:1237\u20131241, 1999.","journal-title":"J Clin Invest"},{"key":"BF03032573_CR40","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<330::AID-PATH588>3.0.CO;2-4","volume":"190","author":"WD Thompson","year":"2000","unstructured":"Thompson WD, Li WW Maragoudakis M: The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies. J Pathol 190:330\u2013337, 2000.","journal-title":"J Pathol"},{"key":"BF03032573_CR41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF03032354","volume":"6","author":"J T\u00edm\u00e1r","year":"2000","unstructured":"T\u00edm\u00e1r J, T\u00f3th J: Tumor sinuses-vascular channels. Pathol Oncol Res 6:83\u201386, 2000.","journal-title":"Pathol Oncol Res"},{"key":"BF03032573_CR42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/01.CIR.94.4.727","volume":"94","author":"CD Venkov","year":"1996","unstructured":"Venkov CD, Rankin AB, Vaughan DE: Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 94:727\u2013733, 1996.","journal-title":"Circulation"},{"key":"BF03032573_CR43","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1067\/mva.2001.112231","volume":"33","author":"C Xu","year":"2001","unstructured":"Xu C, Lee S, Singh TM, et al: Molecular mechanisms of aortic wall remodeling in response to hypertension. J vasc Surg 33:570\u2013578, 2001.","journal-title":"J vasc Surg"},{"key":"BF03032573_CR44","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood.V92.9.3268","volume":"92","author":"ChH Yeh","year":"2000","unstructured":"Yeh ChH, Peng H-Ch, Huang T-F: Accutin, a new desintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin \u03b1v\u03b23 antagonist and inducing apoptosis. Blood 92:3268\u20133276, 2000.","journal-title":"Blood"},{"key":"BF03032573_CR45","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/72303","volume":"6","author":"M Zhang","year":"2000","unstructured":"Zhang M, Volpert O, Shi YH, et al: Maspin is an angiogenesis inhibitor. Nature Medicine 6:196\u2013199, 2000.","journal-title":"Nature Medicine"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03032573.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03032573\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03032573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T14:28:52Z","timestamp":1590157732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03032573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["BF03032573"],"URL":"https:\/\/doi.org\/10.1007\/bf03032573","relation":{},"ISSN":["1219-4956"],"issn-type":[{"value":"1219-4956","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}